Related Experiment Video
Updated: Mar 26, 2026

A Neonatal Rodent Model of Retroorbital Vein Injection
Published on: February 23, 2024
Ophthalmia neonatorum treatment and prophylaxis: IPOSC global study
Ofira Zloto1,2, Almutez Gharaibeh3, Eedy Mezer4
1Department of Ophthalmology, Sheba Medical Center, Goldschleger Eye Institute, Tel Hashomer, 52621, Israel.
Insights
Ophthalmia neonatorum (ON) incidence is low, with Chlamydia trachomatis as the primary cause. Most infants receive erythromycin for treatment and prophylaxis, according to pediatric ophthalmologists.
Area of Science:
- Ophthalmology
- Neonatal Care
- Infectious Diseases
Background:
- Ophthalmia neonatorum (ON) characteristics among pediatric ophthalmologists are not well-defined.
- Understanding current practices is crucial for managing this neonatal condition.
Purpose of the Study:
- To investigate the incidence, diagnosis, treatment, and prophylaxis of ophthalmia neonatorum (ON).
- To gather data from members of the American Association of Paediatric Ophthalmology and Strabismus (AAPOS).
Main Methods:
- A web-based survey was distributed to AAPOS members via email.
- The survey collected data on ON incidence, etiology, diagnosis, treatment, and prophylaxis globally.
Main Results:
- 291 ophthalmologists responded; most (52.94%) were from North America.
- The most frequent pathogen identified was Chlamydia trachomatis (35.37%).
- Erythromycin was the predominant treatment (85.21% for early-onset, 75.09% for late-onset) and prophylactic agent (71.50% for prophylaxis).
Conclusions:
- The incidence of ON per practitioner is typically 0-5 cases annually.
- Chlamydia trachomatis is the leading cause of ON.
- Prophylaxis and treatment are widely administered to affected infants.
Introduction:
Characteristics of ophthalmia neonatorum (ON) amongst paediatric ophthalmologists remain unclear. The purpose of this current study is to examine the incidence, diagnosis, treatment, and prophylaxis of ON cases presenting to members of the American Association of Paediatric Ophthalmology and Strabismus (AAPOS).
Methods:
An email containing a web link to a survey was sent to all members of AAPOS. The questionnaire examined the incidence of ON, etiology, diagnostic methods, treatment, and prophylaxis of the disease in different countries around the world.
Results:
Two hundred and ninety-one ophthalmologists answered the questionnaire. Most were from North America (52.94 %). One hundred and seventy-six (60.69 %) ophthalmologists encountered 0-5 cases of ON per year. The most common pathogens causing ON was Chlamydia trachomatis (35.37 %). Two hundred and forty-two (85.21 %) treat empirically when encountering ON during the first 10 days of life and 205 (75.09 %) after the first 10 days of life. In both cases, erythromycin was the most common first line of treatment. Two hundred and twenty-two (78.72 %) ophthalmologists replied that prophylactic treatment is required in their country. The most common agent for prophylaxis was erythromycin ointment (71.50 %).
Conclusions:
We found that the incidence of ON per year per practitioner is 0-5 cases, the most common etiology is C. trachomatis, and most infants receive prophylaxis and treatment.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Sexually Transmitted Infections
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis II: Management
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...

